Synergy Pharma (SGYP) Shares Slump Early; Allergan Interest Questioned

(Updated - August 24, 2016 9:51 AM EDT)

Synergy Pharma (Nasdaq: SGYP) shares are down early Wednesday. The stock is off around 5 percent with heavy volume at the start. Today's trading action follows a 3 percent drop on Tuesday.

UPDATE - on Mad Money Monday night, Jim Cramer commented:

I don't think that Brent Saunders [CEO of Allergan] is going to buy them ... Look, it's had a good run. It's almost doubled. I would say it's for speculation only. Remember, it can pull back. It's had such a big run.

You May Also Be Interested In

• SEC plans crypto investment regime and tokenized stock exemption - Bloomberg
• Google Gemini now has over 1B monthly users - CEO
• Planet Green halted again, now up 793%